Understanding clinician perspectives on antibiotic associated adverse events to inform feedback
Background: Feedback regarding antibiotic-associated adverse events (ABX-AEs) may assist clinicians with antibiotic decision making. We sought to understand how clinicians account for ABX-AEs when prescribing and their preferences for ABX-AE feedback. Methods: We conducted 1-hour virtual focus group...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2023-06-01
|
| Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X23002656/type/journal_article |
| _version_ | 1797670859577491456 |
|---|---|
| author | Jerald Cherian George Jones Taylor Helsel Zunaira Virk Alejandra Salinas Suzanne Grieb Sara Keller Pranita Tamma Sara Cosgrove |
| author_facet | Jerald Cherian George Jones Taylor Helsel Zunaira Virk Alejandra Salinas Suzanne Grieb Sara Keller Pranita Tamma Sara Cosgrove |
| author_sort | Jerald Cherian |
| collection | DOAJ |
| description | Background: Feedback regarding antibiotic-associated adverse events (ABX-AEs) may assist clinicians with antibiotic decision making. We sought to understand how clinicians account for ABX-AEs when prescribing and their preferences for ABX-AE feedback. Methods: We conducted 1-hour virtual focus groups with 3–5 physicians or advance practice practitioners (APPs) per session at Johns Hopkins Hospital. Participants discussed the role of ABX-AEs in antibiotic decision making and feedback preferences. Participants evaluated prespecified categorization (mildly, moderately, or very concerning) of several ABX-AEs. Focus groups were recorded and transcribed. Transcripts were coded inductively by 2 independent reviewers; discrepancies were resolved by consensus. Codes were used to conduct thematic analysis. Results: Overall, 3 focus groups were conducted with 12 participants: 41.6% were house staff, 16.7% were attending physicians, and 41.6% were APPs. Most were female (91.6%) and were white (41.7%) or Asian (41.7%). Clinicians generally agreed with the prespecified categorizations of ABX-AEs based on degree of clinical concern (Table). We identified 5 themes: (1) The risk of ABX-AE is considered during initial prescribing but influences agent selection more than the decision to prescribe antibiotics. (2) The occurrence of an ABX-AE leads to assessment of need for continued antibiotic therapy. (3) The impact of an ABX-AE on other management decisions is as important as the direct harm of the ABX-AE when assessing severity. (4) Feedback must be curated to prevent clinicians from being overwhelmed with data. (5) Clinicians will be more receptive to feedback regarding ABX-AEs if feedback is contextualized (Fig.). Conclusions: The themes identified and assessment of ABX-AEs of greatest clinical concern may help inform the development of effective ABX-AE feedback methods to improve antibiotic safety. |
| first_indexed | 2024-03-11T21:06:54Z |
| format | Article |
| id | doaj.art-7437e2012b614eb6af42010c9c0014c5 |
| institution | Directory Open Access Journal |
| issn | 2732-494X |
| language | English |
| last_indexed | 2024-03-11T21:06:54Z |
| publishDate | 2023-06-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | Antimicrobial Stewardship & Healthcare Epidemiology |
| spelling | doaj.art-7437e2012b614eb6af42010c9c0014c52023-09-29T12:56:48ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2023-06-013s35s3610.1017/ash.2023.265Understanding clinician perspectives on antibiotic associated adverse events to inform feedbackJerald CherianGeorge JonesTaylor HelselZunaira VirkAlejandra SalinasSuzanne GriebSara KellerPranita TammaSara CosgroveBackground: Feedback regarding antibiotic-associated adverse events (ABX-AEs) may assist clinicians with antibiotic decision making. We sought to understand how clinicians account for ABX-AEs when prescribing and their preferences for ABX-AE feedback. Methods: We conducted 1-hour virtual focus groups with 3–5 physicians or advance practice practitioners (APPs) per session at Johns Hopkins Hospital. Participants discussed the role of ABX-AEs in antibiotic decision making and feedback preferences. Participants evaluated prespecified categorization (mildly, moderately, or very concerning) of several ABX-AEs. Focus groups were recorded and transcribed. Transcripts were coded inductively by 2 independent reviewers; discrepancies were resolved by consensus. Codes were used to conduct thematic analysis. Results: Overall, 3 focus groups were conducted with 12 participants: 41.6% were house staff, 16.7% were attending physicians, and 41.6% were APPs. Most were female (91.6%) and were white (41.7%) or Asian (41.7%). Clinicians generally agreed with the prespecified categorizations of ABX-AEs based on degree of clinical concern (Table). We identified 5 themes: (1) The risk of ABX-AE is considered during initial prescribing but influences agent selection more than the decision to prescribe antibiotics. (2) The occurrence of an ABX-AE leads to assessment of need for continued antibiotic therapy. (3) The impact of an ABX-AE on other management decisions is as important as the direct harm of the ABX-AE when assessing severity. (4) Feedback must be curated to prevent clinicians from being overwhelmed with data. (5) Clinicians will be more receptive to feedback regarding ABX-AEs if feedback is contextualized (Fig.). Conclusions: The themes identified and assessment of ABX-AEs of greatest clinical concern may help inform the development of effective ABX-AE feedback methods to improve antibiotic safety.https://www.cambridge.org/core/product/identifier/S2732494X23002656/type/journal_article |
| spellingShingle | Jerald Cherian George Jones Taylor Helsel Zunaira Virk Alejandra Salinas Suzanne Grieb Sara Keller Pranita Tamma Sara Cosgrove Understanding clinician perspectives on antibiotic associated adverse events to inform feedback Antimicrobial Stewardship & Healthcare Epidemiology |
| title | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
| title_full | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
| title_fullStr | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
| title_full_unstemmed | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
| title_short | Understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
| title_sort | understanding clinician perspectives on antibiotic associated adverse events to inform feedback |
| url | https://www.cambridge.org/core/product/identifier/S2732494X23002656/type/journal_article |
| work_keys_str_mv | AT jeraldcherian understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT georgejones understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT taylorhelsel understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT zunairavirk understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT alejandrasalinas understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT suzannegrieb understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT sarakeller understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT pranitatamma understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback AT saracosgrove understandingclinicianperspectivesonantibioticassociatedadverseeventstoinformfeedback |